Literature DB >> 17016645

Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.

Hany Kayed1, Jörg Kleeff, Shereen Keleg, Xiaohua Jiang, Roland Penzel, Thomas Giese, Hanswalter Zentgraf, Markus W Büchler, Murray Korc, Helmut Friess.   

Abstract

Glypican1 (GPC1) is a cell surface heparan sulfate proteoglycan that acts as a co-receptor for heparin-binding growth factors as well as for members of the TGF-beta family. GPC1 plays a role in pancreatic cancer by regulating growth factor responsiveness. In view of the importance of members of the TGF-beta family in pancreatic cancer, in the present study, the role of GPC1 in TGF-beta, BMP and activin signaling was analyzed. Quantitative RT-PCR and immunohistochemistry were utilized to analyze GPC1 and TGF-beta, BMP and activin receptor expression levels. Panc-1 and T3M4 pancreatic cancer cells were transfected in a stable manner with a GPC1 antisense expression construct. Anchorage-dependent and -independent growth was determined by MTT and soft agar assays. TGF-beta1, activin-A and BMP-2 responsiveness was determined by MTT assays and immunoblotting with p21, p-Smad1, and p-Smad2 antibodies. QRT-PCR demonstrated increased GPC1 mRNA levels in pancreatic ductal adenocarcinoma (PDAC) compared to normal pancreatic tissues (NPT), as described previously. There was a significant correlation between GPC1 mRNA levels and TbetaRII, act-R1a, act-R1b, act-R2a, BMP-R1a, and BMP-R2 mRNA expression in NPT. In contrast, GPC1 mRNA expression correlated directly with act-R1a and BMP-R1a in N0 PDAC cases and with act-R2a and BMP-R1a in lymph node positive cases. Down-regulation of GPC1 resulted in increased doubling time in Panc-1 but not in T3M4 cells, and decreased anchorage-independent growth in both cell lines. GPC1 down-regulation resulted in a slightly altered response towards TGF-beta1, activin-A and BMP-2 in terms of growth, p21 induction and Smad2 phosphorylation. In conclusion, enhanced GPC1 expression correlates with BMP and activin receptors in pancreatic cancer. GPC1 down-regulation suppresses pancreatic cancer cell growth and slightly modifies signaling of members of the TGF-beta family of growth factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016645

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  16 in total

Review 1.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Glypican-1 exosomes: do they initiate a new era for early pancreatic cancer diagnosis?

Authors:  Laura Lorenzon; Giovanni Blandino
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

3.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

4.  Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma.

Authors:  Qingcui Song
Journal:  Dig Dis Sci       Date:  2019-09-26       Impact factor: 3.199

Review 5.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

6.  Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.

Authors:  John B Kisiel; Tracy C Yab; William R Taylor; Suresh T Chari; Gloria M Petersen; Douglas W Mahoney; David A Ahlquist
Journal:  Cancer       Date:  2011-09-22       Impact factor: 6.860

Review 7.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

8.  GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathway.

Authors:  Fei Lu; Shuran Chen; Weijun Shi; Xu Su; Huazhang Wu; Mulin Liu
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

9.  NOTUM Is Involved in the Progression of Colorectal Cancer.

Authors:  Jong Hyuk Yoon; Dayea Kim; Jaeyoon Kim; Hyeongjoo Lee; Jaewang Ghim; Byung Jun Kang; Parkyong Song; Pann-Ghill Suh; Sung Ho Ryu; Taehoon G Lee
Journal:  Cancer Genomics Proteomics       Date:  2018 Nov-Dec       Impact factor: 4.069

10.  Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.

Authors:  Jing-Yu Qian; Yu-Lin Tan; Yang Zhang; Yong-Fei Yang; Xiao-Qiang Li
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.